Filing metadata

Accession number
0001415889-24-027636
Form type
Form 3
Filer
4D Molecular Therapeutics, Inc.
CIK
CIK 1650648
Filed
Nov 25, 2024
Reporting period
Nov 13, 2024
Description
Initial ownership

Explore SEC Filings Hub